Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Efficacy of Duloxetine on Painful Physical Symptoms in Major Depressive Disorder for Patients With Clinically Significant Painful Physical Symptoms at Baseline: A Meta-Analysis of 11 Double-Blind, Placebo-Controlled Clinical Trials PDF $40.00
$40.00
× Placeholder Efficacy of Quetiapine Monotherapy for the Treatment of Depressive Episodes in Bipolar I Disorder: A Post Hoc Analysis of Combined Results From 2 Double-Blind, Randomized, Placebo-Controlled Studies PDF $40.00
$40.00
× Placeholder Impact of the COVID-19 Pandemic on Consultation-Liaison Psychiatry Services: An Exploratory Study From a Tertiary Care Center in North India PDF $40.00
$40.00
× Placeholder Pharmacokinetics, Tolerability, and Clinical Effectiveness of Quetiapine Fumarate: An Open-Label Trial in Adolescents With Psychotic Disorders PDF $40.00
$40.00
× Placeholder Predictors of Loneliness by Age Decade: Study of Psychological and Environmental Factors in 2,843 Community-Dwelling Americans Aged 20-69 Years PDF $40.00
$40.00
× Placeholder Psychiatric Treatment Needs Among the Medically Underserved: A Study of Black and White Primary Care Patients Residing in a Racial Minority Neighborhood PDF $40.00
$40.00
× Placeholder Management of a Psychiatry Inpatient Unit During the COVID-19 Pandemic: An Audit of Services PDF $40.00
$40.00
× Placeholder Exposure to Second-Generation Antipsychotics and Risk of Type 2 Diabetes Mellitus in Adolescents and Young Adults: A Nationwide Study in Taiwan PDF $40.00
$40.00
× Placeholder Prospective Longitudinal Study of Predictors of Postpartum-Onset Depression in Women With a History of Major Depressive Disorder PDF $40.00
$40.00
× Placeholder A Double-Blind Randomized Comparison of Nortriptyline Plus Perphenazine Versus Nortriptyline Plus Placebo in the Treatment of Psychotic Depression in Late Life PDF $40.00
$40.00
× Placeholder A Randomized Placebo-Controlled Trial of Risperidone for the Treatment of Aggression, Agitation, and Psychosis of Dementia PDF $40.00
$40.00
× Placeholder Comorbidity Patterns of Anxiety and Depressive Disorders in a Large Cohort Study: the Netherlands Study of Depression and Anxiety (NESDA) PDF $40.00
$40.00
× Placeholder Maintenance Treatment With Risperidone or Low-Dose Haloperidol in First-Episode Schizophrenia: 1-Year Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia PDF $40.00
$40.00
× Placeholder What Is the Threshold for Symptomatic Response and Remission for Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, and Generalized Anxiety Disorder? PDF $40.00
$40.00
× Placeholder Identification of High-Risk Coronary Heart Disease Patients Receiving Atypical Antipsychotics: Single Low-Density Lipoprotein Cholesterol Threshold or Complex National Standard? PDF $40.00
$40.00
× Placeholder Medication Status and Polycystic Ovary Syndrome in Women With Bipolar Disorder: A Preliminary Report PDF $40.00
$40.00
× Placeholder A Randomized Controlled Trial of Risperidone and Olanzapine for Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $680.00
Total $680.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe